Glaxo Could Face $6bn Avandia Liability, Says UBS

March 5, 2010

Latest from cGMPs

Sponsored Content

White paper: Enhancing virus clearance process capability using a biodegradable detergent

Shutterstock 638418178

Key considerations for CGMP raw materials compliance

Intas hit with FDA warning letter

Pm22 Hero 854x480 Quality

Beyond ‘good’ practices